Actively Recruiting
Observational Study Evaluating Minimally Invasive Surgery in Closed Excisional Hemorrhoidectomy for Grade IIIIV Hemorrhoids
Led by Hospital Son Llatzer · Updated on 2026-09-22
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Hemorrhoids are vascular structures in the anal canal that help maintain continence. When these enlarge and descend, they cause symptoms like rectal bleeding and swelling, known as hemorrhoidal syndrome. Advanced hemorrhoids Grade III-IV generally require surgery, with closed excisional hemorrhoidectomy CEH being a standard but painful treatment. Minimally invasive surgery MIS aims to reduce tissue damage and improve healing but has not yet been studied for CEH. This study follows the IDEAL framework Phase 2a to optimize and define this surgical innovation based on clinical practice. The study evaluates the use of minimally invasive surgery in CEH for patients with symptomatic Grade IIIIV hemorrhoids. This approach is expected to reduce postoperative pain and speed recovery while maintaining CEHs effectiveness. The technique uses enhanced visualization for surgical precision, though it may initially take longer and requires a learning curve. The study is observational and aims to assess how reproducible this MIS technique is in CEH. Participants are adults over 18 years with Grade IIIIV hemorrhoids who consent to surgery. Researchers will monitor surgical reproducibility and safety over 30 days post-surgery, assess pain and analgesic use during the first 14 days, and evaluate symptoms and health status for up to one year. Adverse events and clinical failure rates will also be tracked. The study duration extends through one year after surgery with ongoing assessments to gather comprehensive recovery and outcome data.
CONDITIONS
Brief Title
Minimaly Ivnasive Surgery for Grade III Hemorrhoids
Research Team
I
Ignacio Fernandez-Hurtado, Colorectal Surgeon
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here